Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells.
Hsiao FC, Lin M, Tai A, Chen G, Huber BT, J Immunol, 2006 Aug 15 - link